Recently, participation of HDAC2 in bone cancer pain and chronic pancreatitis pain was proposed, as a favorable pain-relieving effect was observed after HDAC2 knockdown or inhibition (Hu et al., 2017; Hou et al., 2018; Liao et al., 2018). This evidence concerns the gene HDAC2 and bone neoplasm.